secwatch.observer — SEC 8-K summary
======================================

Issuer:     GALECTIN THERAPEUTICS INC (GALT)
CIK:        0001133416
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001140361-25-044711
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galectin Therapeutics shareholders elect all 11 directors, approve say-on-pay, set frequency at 3 years
--------------------------------------------------------------------------------

- All 11 director nominees elected with >25M votes for each; highest was Benjamin S. Carson Sr. at 25.9M.
- Advisory say-on-pay resolution approved: 25.3M for, 639k against, 310k abstain.
- Shareholders chose a 3-year frequency for future say-on-pay votes (22.1M votes for 3 years).
- Ratification of Cherry Bekaert LLP as independent auditor for FY2025 passed with 45.5M for, 142k against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133416/000114036125044711/0001140361-25-044711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133416/000114036125044711/ef20060738_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-044711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer